ATG induction therapy and the incidence of bronchiolitis obliterans after lung transplantation: does it make a difference?

Transplant Proc. 1998 Jun;30(4):1517-8. doi: 10.1016/s0041-1345(98)00340-6.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Antilymphocyte Serum / therapeutic use*
  • Bronchiolitis Obliterans / epidemiology*
  • Bronchiolitis Obliterans / pathology
  • Bronchiolitis Obliterans / prevention & control
  • Disease-Free Survival
  • Follow-Up Studies
  • Heart-Lung Transplantation / immunology
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Incidence
  • Lung Transplantation / immunology*
  • Lung Transplantation / mortality
  • Lung Transplantation / pathology
  • Postoperative Complications
  • Retrospective Studies
  • Survival Analysis
  • Time Factors

Substances

  • Antilymphocyte Serum
  • Immunosuppressive Agents